(Q36774698)

16 August 2017

1 reference

title

Challenges in the design and conduct of therapeutic trials in channel disorders (English)

1 reference

16 August 2017

Shannon L Venance

1

1 reference

16 August 2017

Barbara E Herr

series ordinal

2

1 reference

16 August 2017

Robert C Griggs

series ordinal

3

1 reference

16 August 2017

publication date

1 April 2007

1 reference

16 August 2017

1 reference

16 August 2017

volume

4

1 reference

16 August 2017

issue

2

1 reference

16 August 2017

page(s)

199-204

1 reference

https://scigraph.springernature.com/pub.10.1016/j.nurt.2007.01.004

16 August 2017

exact match

0 references

cites work

Physiologic principles underlying ion channelopathies

1 reference

https://api.crossref.org/works/10.1016%2FJ.NURT.2007.01.004

Adopting orphan drugs--two dozen years of treating rare diseases.

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.NURT.2007.01.004

A journey of hope: lessons learned from studies on rare diseases and orphan drugs

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.NURT.2007.01.004

The primary periodic paralyses: diagnosis, pathogenesis and treatment

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.NURT.2007.01.004

Clinical trials and rare diseases

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.NURT.2007.01.004

Comparative responsiveness of generic and specific quality-of-life instruments

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.NURT.2007.01.004

Neonatal epilepsy syndromes and GEFS+: mechanistic considerations

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.NURT.2007.01.004

Management and treatment of Andersen-Tawil syndrome (ATS).

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.NURT.2007.01.004

Clinical spectrum of episodic ataxia type 2.

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.NURT.2007.01.004

Episodic ataxia type 1: a neuronal potassium channelopathy

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.NURT.2007.01.004

21 January 2018

Episodic ataxia type 2.

1 reference

https://api.crossref.org/works/10.1016%2FJ.NURT.2007.01.004

Channelopathies in idiopathic epilepsy

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.NURT.2007.01.004

Autoimmune and paraneoplastic channelopathies

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.NURT.2007.01.004

Genetic mechanisms that underlie epilepsy

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.NURT.2007.01.004

Pathomechanisms in channelopathies of skeletal muscle and brain

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.NURT.2007.01.004

SCN4A-associated hypokalemic periodic paralysis merits a trial of acetazolamide

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.NURT.2007.01.004

New mutations of SCN4A cause a potassium-sensitive normokalemic periodic paralysis

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.NURT.2007.01.004

The therapy of congenital myasthenic syndromes

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.NURT.2007.01.004

Muscle channelopathies and critical points in functional and genetic studies

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.NURT.2007.01.004

Treatment of slow-channel congenital myasthenic syndrome with fluoxetine

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.NURT.2007.01.004

Anxiety, affect, and activity in teenagers: monitoring daily life with electronic diaries

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.NURT.2007.01.004

The emerging role of electronic diaries in the management of diabetes mellitus

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.NURT.2007.01.004

Patient compliance with paper and electronic diaries

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.NURT.2007.01.004

Memory for pain: relation between past and present pain intensity.

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.NURT.2007.01.004

Clinical evaluation of membrane excitability in muscle channel disorders: potential applications in clinical trials

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.NURT.2007.01.004

Treatment of episodic ataxia type 2 with the potassium channel blocker 4-aminopyridine

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.NURT.2007.01.004

Ion channels and epilepsy

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.NURT.2007.01.004

Diverse mechanisms of antiepileptic drugs in the development pipeline

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.NURT.2007.01.004

Acetazolamide acts directly on the human skeletal muscle chloride channel

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.NURT.2007.01.004

Andersen's syndrome: A distinct periodic paralysis

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.NURT.2007.01.004

Treatment of "permanent" muscle weakness in familial Hypokalemic Periodic Paralysis

21 January 2018

1 reference

12 December 2020

Carbonic anhydrase inhibitors are specific openers of skeletal muscle BK channel of K+-deficient rats.

1 reference

12 December 2020

Electromyography guides toward subgroups of mutations in muscle channelopathies.

1 reference

12 December 2020

1 reference

12 December 2020

Randomized trials of dichlorphenamide in the periodic paralyses. Working Group on Periodic Paralysis

1 reference

12 December 2020

Cold extends electromyography distinction between ion channel mutations causing myotonia

1 reference

12 December 2020

Developing new treatments for muscle disease: prospects and promise.

1 reference

12 December 2020

Determining optimal therapy--randomized trials in individual patients

1 reference

12 December 2020

Acetazolamide treatment of hypokalemic periodic paralysis. Prevention of attacks and improvement of persistent weakness

1 reference

12 December 2020

N-of-1 trials: innovative methods to evaluate complementary and alternative medicines in pediatric cancer

1 reference

12 December 2020

10.1016/J.NURT.2007.01.004

Identifiers

DOI

1 reference

Dimensions Publication ID

16 August 2017

1037404140

0 references

1 reference